Elias D, Marcus H, Reshef T, Ablamunits V, Cohen I R
Department of Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Eur J Immunol. 1995 Oct;25(10):2851-7. doi: 10.1002/eji.1830251021.
We previously reported that immunity to the p277 peptide of the human 60-kDa heat shock protein (hsp60) was a causal factor in the diabetes of non-obese diabetic (NOD) mice, which are genetically prone to develop spontaneous autoimmune diabetes. The present study was done to test whether immunization with the p277 peptide could cause diabetes in standard strains of mice. We now report that a single administration of the p277 peptide conjugated to carrier molecules such as bovine serum albumin or ovalbumin can induce diabetes in C57BL/6 mice and in other strains not genetically prone to develop diabetes. The diabetes was marked by hyperglycemia, insulitis, insulin autoantibodies, glucose intolerance and low blood levels of insulin. The diabetes could be transferred to naive recipients by anti-p277 T cell lines. Similar to other experimentally induced autoimmune diseases, the autoimmune diabetes remitted spontaneously. After recovery, the mice were found to have acquired resistance to a second induction of diabetes. Susceptibility to induced diabetes in C57BL/6 mice was influenced by sex (males were much more susceptible than were females) and by class II genes in the major histocompatibility complex (B6.H-2bm12 mice with a mutation in the MHC-II molecule were relatively resistant). Other strains of mice susceptible to induced diabetes were C57BL/KSJ, C3HeB/FeJ, and NON/Lt. BALB/c and C3H/HeJ strains were relatively resistant. Immunization to p277-carrier conjugates could also induce transient hyperglycemia in young NOD mice, but upon recovery from the induced diabetes, the NOD mice were found to have acquired resistance to later development of spontaneous diabetes. Thus, T cell immunity to the p277 peptide can suffice to induce diabetes in standard mice, and a short bout of induced diabetes can affect the chronic process that would otherwise lead to spontaneous diabetes in diabetes-prone NOD mice.
我们先前曾报道,对人60 kDa热休克蛋白(hsp60)的p277肽的免疫反应是导致非肥胖糖尿病(NOD)小鼠患糖尿病的一个致病因素,这些小鼠具有遗传易感性,易发生自发性自身免疫性糖尿病。本研究旨在测试用p277肽免疫是否会在标准品系小鼠中引发糖尿病。我们现在报告,单次给予与载体分子如牛血清白蛋白或卵清蛋白偶联的p277肽可在C57BL/6小鼠及其他无遗传易感性患糖尿病的品系小鼠中诱发糖尿病。糖尿病的特征为高血糖、胰岛炎、胰岛素自身抗体、葡萄糖不耐受以及胰岛素血浓度降低。糖尿病可通过抗p277 T细胞系转移至未接触过该抗原的受体小鼠。与其他实验诱导的自身免疫性疾病相似,自身免疫性糖尿病可自发缓解。恢复后,发现这些小鼠对再次诱导糖尿病具有抵抗力。C57BL/6小鼠对诱导糖尿病的易感性受性别影响(雄性比雌性更易感)以及主要组织相容性复合体中的II类基因影响(MHC-II分子发生突变的B6.H-2bm12小鼠相对具有抵抗力)。其他易患诱导性糖尿病的小鼠品系有C57BL/KSJ、C3HeB/FeJ和NON/Lt。BALB/c和C3H/HeJ品系相对具有抵抗力。对p277-载体偶联物的免疫也可在年轻的NOD小鼠中诱导短暂的高血糖,但从诱导的糖尿病恢复后,发现NOD小鼠对随后发生的自发性糖尿病具有抵抗力。因此,针对p277肽的T细胞免疫足以在标准小鼠中诱发糖尿病,且短暂的诱导性糖尿病发作可影响原本会导致易患糖尿病的NOD小鼠发生自发性糖尿病的慢性进程。